Focused Wealth Management, Inc - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 37 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$14,000
-53.3%
10,000
-50.0%
0.00%
-60.0%
Q3 2017$30,000
+15.4%
20,0000.0%0.01%0.0%
Q2 2017$26,000
+116.7%
20,000
+100.0%
0.01%
+100.0%
Q1 2017$12,00010,0000.01%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Verity Asset Management, Inc. 85,378$301,0000.33%
Tower Research Capital LLC (TRC) 54,690$193,0000.03%
Psagot Value Holdings Ltd. 54,348$191,0000.01%
OPPENHEIMER & CO INC 36,450$128,0000.00%
MEEDER ASSET MANAGEMENT INC 2,900$10,0000.00%
TWO SIGMA INVESTMENTS, LP 34,571$121,0000.00%
Commonwealth Equity Services, Inc 11,100$39,0000.00%
GROUP ONE TRADING, L.P. 18,844$66,0000.00%
CITIGROUP INC 737$3,0000.00%
VAN ECK ASSOCIATES CORP 21,179$75,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders